Suchergebnisse - "Bibi, Nousheen"

PubPharm (23)

1

Screening and computational analysis of colorectal associated non-synonymous polymorphism in CTNNB1 gene in Pakistani population

enthalten in: BMC medical genetics | 2019

von Razak, S. | Bibi, N. | Dar, J. | +4

ErratumIn: BMC Med Genet. 2020 Feb 24;21(1):39. - PMID 32093642

2

Screening and computational analysis of colorectal associated non-synonymous polymorphism in CTNNB1 gene in Pakistani population

enthalten in: BMC medical genetics | 2019

von Razak, S. | Bibi, N. | Dar, J. | +4

3

Screening and computational analysis of colorectal associated non-synonymous polymorphism in CTNNB1 gene in Pakistani population

enthalten in: BMC medical genetics | 2019

von Razak, S. | Bibi, N. | Dar, J. | +4

4

In Silico Structure Modeling and Molecular Docking Analysis of Phosphoribosyl Pyrophosphate Amidotransferase (PPAT) with Antifolate Inhibitors

enthalten in: Current cancer drug targets | 2019

von Bibi, N. | Parveen, Z. | Nawaz, M. | +1

5

Screening and Identification of PLK1-Polo Box Binding Peptides by High-Throughput Sequencing of Phage-Selected Libraries

enthalten in: Protein and peptide letters | 2019

von Bibi, N. | Niaz, H. | Hupp, T. | +2

6

An Integrative "Omics" Approach, for Identification of Bona Fides PLK1 Associated Biomarker in Esophageal Adenocarcinoma

enthalten in: Current cancer drug targets | 2019

von Bibi, N. | Rashid, S. | Nicholson, J. | +4

7

An Integrative “Omics” Approach, for Identification of Bona Fides PLK1 Associated Biomarker in Esophageal Adenocarcinoma

enthalten in: Current cancer drug targets | 2019

von Bibi, N. | Rashid, S. | Nicholson, J. | +4

8

Inhibitory Mechanism of An Anticancer Drug, Bexarotene Against Amyloid β Peptide Aggregation: Repurposing Via Neuroinformatics Approach

enthalten in: Current pharmaceutical design | 2019

von Bibi, N. | Rizvi, S. | Batool, A. | +1

9

In Silico Structure Modeling and Molecular Docking Analysis of Phosphoribosyl Pyrophosphate Amidotransferase (PPAT) with Antifolate Inhibitors

enthalten in: Current cancer drug targets | 2019

von Bibi, N. | Parveen, Z. | Nawaz, M. | +1

10

Inhibitory Mechanism of An Anticancer Drug, Bexarotene Against Amyloid β Peptide Aggregation : Repurposing Via Neuroinformatics Approach

enthalten in: Current pharmaceutical design | 2019

von Bibi, N. | Rizvi, S. | Batool, A. | +1